Cargando…

Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model

OBJECTIVES: The public health impact of nicotine vaping products (NVPs) is subject to complex transitions between NVP and cigarette use. To circumvent the data limitations and parameter instability challenges in modeling transitions, we indirectly estimate NVPs’ impact on smoking prevalence and resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, David T., Cadham, Christopher J., Yuan, Zhe, Li, Yameng, Gravely, Shannon, Cummings, K. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661672/
https://www.ncbi.nlm.nih.gov/pubmed/37540451
http://dx.doi.org/10.17269/s41997-023-00792-3
_version_ 1785138028483706880
author Levy, David T.
Cadham, Christopher J.
Yuan, Zhe
Li, Yameng
Gravely, Shannon
Cummings, K. Michael
author_facet Levy, David T.
Cadham, Christopher J.
Yuan, Zhe
Li, Yameng
Gravely, Shannon
Cummings, K. Michael
author_sort Levy, David T.
collection PubMed
description OBJECTIVES: The public health impact of nicotine vaping products (NVPs) is subject to complex transitions between NVP and cigarette use. To circumvent the data limitations and parameter instability challenges in modeling transitions, we indirectly estimate NVPs’ impact on smoking prevalence and resulting smoking-attributable deaths using the SimSmoke simulation model. METHODS: Canada SimSmoke uses age- and sex-specific data on Canadian population, smoking prevalence and tobacco control policies. The model incorporates the impact of cigarette-oriented policies on smoking prevalence but not the explicit contribution of NVPs. The model was calibrated from 1999 to 2012, thereby projecting smoking prevalence before NVPs were widely used in Canada. The NVP impact on smoking prevalence is inferred by comparing projected 2012–2020 smoking trends absent NVPs to corresponding trends from two Canadian national surveys. We further distinguish impacts before and after NVPs became regulated in 2018 and more available. RESULTS: Comparing 2012–2020 survey data of post-NVP to SimSmoke projected smoking prevalence trends, one survey indicated an NVP-related relative reduction of 15% (15%) for males (females) age 15+, but 32% (52%) for those ages 15–24. The other survey indicated a 14% (19%) NVP-related smoking reduction for ages 18+, but 42% (53%) for persons ages 18–24. Much of the gain occurred since Canada relaxed NVP restrictions. NVP-related 2012–2020 smoking reductions yielded 100,000 smoking-attributable deaths averted from 2012 to 2060. CONCLUSION: Smoking prevalence in Canada, especially among younger adults, declined more rapidly once NVPs became readily available. The emergence of NVPs into the Canadian marketplace has not slowed the decline in smoking. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.17269/s41997-023-00792-3.
format Online
Article
Text
id pubmed-10661672
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106616722023-08-04 Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model Levy, David T. Cadham, Christopher J. Yuan, Zhe Li, Yameng Gravely, Shannon Cummings, K. Michael Can J Public Health Population Health Intervention Research OBJECTIVES: The public health impact of nicotine vaping products (NVPs) is subject to complex transitions between NVP and cigarette use. To circumvent the data limitations and parameter instability challenges in modeling transitions, we indirectly estimate NVPs’ impact on smoking prevalence and resulting smoking-attributable deaths using the SimSmoke simulation model. METHODS: Canada SimSmoke uses age- and sex-specific data on Canadian population, smoking prevalence and tobacco control policies. The model incorporates the impact of cigarette-oriented policies on smoking prevalence but not the explicit contribution of NVPs. The model was calibrated from 1999 to 2012, thereby projecting smoking prevalence before NVPs were widely used in Canada. The NVP impact on smoking prevalence is inferred by comparing projected 2012–2020 smoking trends absent NVPs to corresponding trends from two Canadian national surveys. We further distinguish impacts before and after NVPs became regulated in 2018 and more available. RESULTS: Comparing 2012–2020 survey data of post-NVP to SimSmoke projected smoking prevalence trends, one survey indicated an NVP-related relative reduction of 15% (15%) for males (females) age 15+, but 32% (52%) for those ages 15–24. The other survey indicated a 14% (19%) NVP-related smoking reduction for ages 18+, but 42% (53%) for persons ages 18–24. Much of the gain occurred since Canada relaxed NVP restrictions. NVP-related 2012–2020 smoking reductions yielded 100,000 smoking-attributable deaths averted from 2012 to 2060. CONCLUSION: Smoking prevalence in Canada, especially among younger adults, declined more rapidly once NVPs became readily available. The emergence of NVPs into the Canadian marketplace has not slowed the decline in smoking. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.17269/s41997-023-00792-3. Springer International Publishing 2023-08-04 /pmc/articles/PMC10661672/ /pubmed/37540451 http://dx.doi.org/10.17269/s41997-023-00792-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Population Health Intervention Research
Levy, David T.
Cadham, Christopher J.
Yuan, Zhe
Li, Yameng
Gravely, Shannon
Cummings, K. Michael
Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title_full Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title_fullStr Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title_full_unstemmed Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title_short Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
title_sort comparison of smoking prevalence in canada before and after nicotine vaping product access using the simsmoke model
topic Population Health Intervention Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661672/
https://www.ncbi.nlm.nih.gov/pubmed/37540451
http://dx.doi.org/10.17269/s41997-023-00792-3
work_keys_str_mv AT levydavidt comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel
AT cadhamchristopherj comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel
AT yuanzhe comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel
AT liyameng comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel
AT gravelyshannon comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel
AT cummingskmichael comparisonofsmokingprevalenceincanadabeforeandafternicotinevapingproductaccessusingthesimsmokemodel